Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.49 |
| ▸ | GRM8 | O00222 | 1/20 | 0.48 |
| ▸ | GRM6 | O15303 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.48 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.48 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.48 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.48 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.48 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL345917 | 1.00 | NOD1 (0.52) | NOD1S1PR1S1PR3GRM8GRM6 | |
| SCHEMBL18030282 | 1.00 | NOD1 (0.52) | NOD1S1PR1S1PR3GRM8GRM6 | |
| Hydrochloric Acid SCHEMBL8725894 | 0.98 | NOD1 (0.51) | NOD1S1PR1S1PR3GRM8GRM6 | |
| Hydrochloric Acid SCHEMBL14719874 | 0.98 | NOD1 (0.51) | NOD1S1PR1S1PR3GRM8GRM6 | |
| SCHEMBL30559 | 0.95 | NOD1 (0.58) | NOD1S1PR1S1PR3GRM8GRM6 | |
| SCHEMBL16124530 | 0.95 | NOD1 (0.58) | NOD1S1PR1S1PR3GRM8GRM6 | |
| Hydrochloric Acid SCHEMBL23510799 | 0.93 | NOD1 (0.56) | NOD1S1PR1S1PR3GRM8GRM6 | |
| SCHEMBL5495191 | 0.93 | NOD1 (0.56) | NOD1S1PR1S1PR3GRM8GRM6 | |
| SCHEMBL7781960 | 0.93 | NOD1 (0.60) | NOD1S1PR1S1PR3ALDH1A1PPARG | |
| SCHEMBL1220169 | 0.93 | NOD1 (0.60) | NOD1S1PR1S1PR3ALDH1A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023040793-A1 | ANTI-INFLAMMATORY COMPOUND AND USE THEREOF | 映恩生物制药（苏州）有限公司 | 2023-03-23 | — | — | WO | disclosed |
| CN-112812009-B | Preparation method of 2-bromo-dibutyl glutarate | 江苏恒沛药物科技有限公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-112812009-A | Preparation method of 2-bromo-dibutyl glutarate | 江苏恒沛药物科技有限公司 | 2021-05-18 | — | — | CN | disclosed |
| EP-3684416-A1 | PSMA-TARGETING AMANITIN CONJUGATES | Heidelberg Pharma Research GmbH (DE) | 2020-07-29 | — | — | EP | disclosed |
| CN-108218739-B | Butyrylglutamic acid derivative, and composition and application thereof | 广州英赛特生物技术有限公司 | 2020-05-01 | — | — | CN | disclosed |
| WO-2019057964-A1 | PSMA-TARGETING AMANITIN CONJUGATES | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2019-03-28 | — | — | WO | disclosed |
| CN-106518702-A | Aspergillomarasimine A and derivative, synthetic method and application thereof | 北京大学 | 2017-03-22 | — | — | CN | disclosed |
| EP-3021879-A2 | METHODS, SYSTEMS, AND COMPOSITIONS FOR PROMOTING BONE GROWTH | Cayman Chemical Company, Incorporated (US) | 2016-05-25 | — | — | EP | disclosed |
| EP-2989098-A2 | LACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASES AND CONDITIONS | Cayman Chemical Company, Incorporated (US) | 2016-03-02 | — | — | EP | disclosed |
| US-20150175530-A1 | ANTIBACTERIAL AGENTS | ACHAOGEN, INC. | 2015-06-25 | — | — | US | disclosed |
| EP-1656390-A2 | COMPOSITIONS OF LIPOPEPTIDE ANTIBIOTIC DERIVATIVES AND METHODS OF USE THEREOF | MIGENIX INC. (CA) | 2006-05-17 | — | — | EP | disclosed |
| EP-1335898-B1 | CARBAMIC ACID COMPOUNDS COMPRISING AN AMIDE LINKAGE AS HDAC INHIBITORS | TOPOTARGET UK LTD (GB) | 2005-11-23 | — | — | EP | disclosed |
| WO-2005000878-A2 | COMPOSITIONS OF LIPOPEPTIDE ANTIBIOTIC DERIVATIVES AND METHODS OF USE THEREOF | MIGENIX INC. (CA) | 2005-01-06 | — | — | WO | disclosed |
| EP-1335898-A1 | CARBAMIC ACID COMPOUNDS COMPRISING AN AMIDE LINKAGE AS HDAC INHIBITORS | Prolifix Limited (GB) | 2003-08-20 | — | — | EP | disclosed |
| CN-1098908-C | Compound film with colour changing according to absorbed moisture quantity and making method thereof | GUANGZHOU INST OF CHEMISTRY (CN) | 2003-01-15 | — | — | CN | disclosed |
| WO-2002026696-A1 | CARBAMIC ACID COMPOUNDS COMPRISING AN AMIDE LINKAGE AS HDAC INHIBITORS | PROLIFIX LIMITED (GB) | 2002-04-04 | — | — | WO | disclosed |
| CN-1060504-C | Solid composite colour film and manufacture thereof | GUANGZHOU CHEM INST (CN) | 2001-01-10 | — | — | CN | disclosed |
| CN-1223289-A | Compound film with colour changing according to absorbed moisture quantity and making method thereof | GUANGZHOU INST OF CHEMISTRY (CN) | 1999-07-21 | — | — | CN | disclosed |
| CN-1178328-A | Solid composite colour film and manufacture thereof | GUANGZHOU CHEM INST (CN) | 1998-04-08 | — | — | CN | disclosed |
| CN-1076704-A | Solid composite colour film and method for making with cholester structure | GUANGZHOU CHEM INST (CN) | 1993-09-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150175530-A1 | ANTIBACTERIAL AGENTS | MRPL21, ABCB11, LSS | NOD1 775/4885S1PR1 2966/4885S1PR3 3538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.